December 09, 2025 – ZayaAI, a health-tech company dedicated to enhancing the power of pathologists through a next-generation Pathology LIS and AI tools, and Lumea, the U.S. leader in primary clinical digital pathology, today announced a strategic collaboration to embed Lumea’s efficient and intuitive whole-slide image viewer directly into the Zaya Pathology LIS. This integration creates a unified digital environment for case management and image review, helping diagnostic labs accelerate their transition to routine digital pathology.
By combining Zaya’s LIS with Lumea’s digital pathology viewer, pathologists can open, navigate, and annotate slides within the same workspace they use to manage cases and reports—removing the need to jump between separate systems or applications. The integrated solution is being rolled out with initial Zaya LIS sites and will be available to both new and existing customers who select the Lumea viewer option.
“Embedding the Lumea viewer inside Zaya LIS lets pathologists work in one seamless digital workspace—from accessioning to diagnosis—without juggling multiple systems. This collaboration is a key step toward making high-quality digital pathology usable in everyday routine, not just in pilot projects,” said Cristian Mogodici, CEO of ZayaAI.
For diagnostic pathology labs, hospitals, and reference centers, the partnership delivers a single environment for case management, image review, and future AI workflows. In addition to efficiency gains, labs may find it easier to extend digital pathology into more day-to-day practices and to reduce turnaround time for tests and results.
“We’re very excited about this partnership. At Lumea, we know that true digital transformation is about more than just imaging; it’s about delivering actionable data to the clinician when it matters most. This is one more positive step in that direction,” said James Thackeray, Lumea CEO.
Together, ZayaAI and Lumea aim to support laboratories and health systems as they scale digital pathology, expand access to advanced diagnostics, and ultimately enhance cancer patient care.
About Lumea
Lumea is powering efficient, affordable, and accessible digital pathology through simplified, workflow-driven innovation with both tissue-handling technology and a best-in-class viewer with AI-driven workflows. As the U.S. leader in primary clinical digital pathology, processing the highest volume of digital cases nationwide, Lumea has set the standard for efficiency, quality, and premium cancer diagnostics. With a global presence spanning five continents, Lumea supports over half of the U.S. urology market and top dermatology and gastroenterology groups, optimizing tissue integrity, boosting detection rates, and delivering measurable ROI. By placing patients at the core, Lumea is transforming pathology for a more precise and efficient future. Learn more at lumeadigital.com.
About ZayaAI
ZayaAI is a health-tech company dedicated to enhancing the power of pathologists through a next-generation Pathology LIS and AI tools. Zaya Pathology LIS digitalizes the entire workflow—from case registration and macroscopy to slide scanning, reporting and QA—while supporting strict data protection and regulatory requirements. Designed as an AI-ready, cloud-enabled platform with embedded viewing, OCR and speech-to-text, Zaya helps labs standardize processes and reduce turnaround time. Learn more at https://www.zaya.ai/